Expression and clinical significance of metastasis-related tumor markers in colorectal cancer

Chinese Journal of Cancer

Volumn 28, Issue 9, 2009, Pages

  Wan, Xiang Bin ^a   Pan, Zhi Zhong ^a   Ren, Ying kun ^a   Ding, Pei Rong ^a   Chen, Gong ^a   Wan, De Sen ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Colorectal neoplasm; Immunohistochemistry; Tissue microarray; Tumor marker

Indexed keywords

CD44V6 ANTIGEN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENCE RISK; SURVIVAL TIME;

EID: 79955784164     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10185     Document Type: Article

References (14)

1. Wan DS, Chen G. Recent reseach of epidemiology and risk factor of colorectal cancer [J]. Pract J Cancer, 2000, 15(2): 220-222. [in Chinese]
2. Kawasaki H, Altieri DC, Lu CD. Inhibition of apoptosis by surviving predicts shorter survival rates in colorectal cancer [J]. Cancer Res, 1998, 58(22): 5071-5074.
3. Sun Q, Ding YQ, Gao XQ, et al. Development and application of cDNA microarray of tumor metastasis-associated genes [J]. J First Military Med Univ, 2002, 22(4): 1070-1075. [in Chinese]
4. Shi LZ, Wang ZC. Relationship between the expression of EGF, EGFR and PCNA with clinicopathological characteristics in human colorectal carcinoma [J]. Chin J Gen Surgery, 2004, 13(4): 253-256. [in Chinese]
5. Radinsky R, Risin S, Fan D, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells [J]. Clin Cancer Res, 1995, 1(1): 19-31.
6. Cascinu S, Staccioli MP, Gasparina G, et al. Expression of vascular endothelial growth factor can predict event-free survival in stage ¢ò colon cancer [J]. Clin Cancer Res, 2000, 6(7): 2803-2807.
7. Wang YF, Wei B, Ouyang Q. CD44v6 expression in colorectal carcinoma and its clinical significance [J]. Sichuan Med J, 2005, 26(12): 1391-1392. [in Chinese]
8. Pesta M, Holubec L, Topolcan O, et al. Quantitative estimation of matrix metalloproteinases 2 and 7(MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2(TIMP-1, TIMP-2) in colorectal carcinoma tissue samples [J]. Anticancer Res, 2005, 25(5): 3387-3391.
9. Wu ZY, Luo ZR, Wan J, et al. Relationship between expression of E-cadherin, MMP-2 and VEGF and metastasis in colorectal cancer of middle and inferior segment [J]. Chin J Gen Surg, 2007, 16(4): 387-389. [in Chinese]
10. Ring P, Johansson K, Hoyhtya M, et al. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage [J]. Br J Cancer, 1997, 76(6): 805-811.
11. Saukkonen K, Tomasetto C, Narko K, et al. Cyclooproteinases-2 expression and effect of celecoxib in gastric adenomas of trefoil 1-deficient mice [J]. Cancer Res, 2003, 63(12): 3032-3036.
12. Tomozawa S, Tsuno N, Sunami E, et al. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer [J]. Br J Cancer, 2000, 83(3): 324-328.
13. Tsujii M, Kawano S, Dubois R. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential [J]. Proc Natl Acad Sci USA, 1997, 94(7): 3336-3340.
14. Chen C, Chen LQ, Yang GL, et al. Value of tumur markers in diagnosis and monitoring colorectal cancr and strategies for further improvement: analysis of 130 cases [J]. Ai Zheng, 2007, 26(11): 1221-1226. [in Chinese]